Mitral Valve Incompetence
10
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
88%
7 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (10)
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
AltaValve Pivotal Trial
Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis
AltaValve Early Feasibility Study Protocol
AVJ-514 Japan Trial
Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
EVEREST II Pivotal Study High Risk Registry (HRR)
Feasibility Study of a Percutaneous Mitral Valve Repair System.
Pivotal Study of a Percutaneous Mitral Valve Repair System